← Back to headlines
Wegovy jab 'may carry higher risk of sudden sight loss'
The weight-loss jab Wegovy may carry the highest risk of sudden sight loss compared to other semaglutide drugs such as Ozempic, according to new analysis.
11 Mar, 00:00 — 11 Mar, 00:00
Sources
Showing 1 of 1 sources
Related Stories
SC directs Centre to frame no-fault compensation policy for serious adverse events post COVID-19 vaccination
23m ago
Why a PIL wants victims of forceful acid ingestion recognised under the disability law
37m ago
HPV vaccination drive: Delhi sees only 285 jabs in first 10 days, officials blame exams exams for low turnout
1h ago
Millennial Men Face Low Testosterone Crisis, Doctors Warn
1h ago